Urology

Recruiting NCT07406282☆ Save

A Study to Learn About Real-world Utilization and Outcomes of Darolutamide and Other Androgen Receptor Pathway Inhibitors (ARPIs) for Newly Diagnosed Metastatic Hormone-sensitive Prostate Cancer (de Novo mHSPC) in US Urology Clinics

— Observational United States

Prostatic Neoplasms · Metastatic Hormone-Sensitive Prostate Cancer

Not yet recruiting NCT07686744☆ Save

Neoantigen Peptide Vaccine Plus Pembrolizumab in Renal Cell Carcinoma

Phase I Interventional China

Renal Cell Carcinoma · Advanced · Recurrent

Recruiting NCT05521698☆ Save

A Randomized Trial of Bicalutamide in Non-Muscle Invasive Bladder Cancer

Phase I Interventional United States

Non-Muscle Invasive Bladder Urothelial Carcinoma · Recurrent Non-Muscle Invasive Bladder Urothelial Carcinoma

Recruiting NCT06927635☆ Save

Stereotactic Body Radiotherapy or Standard of Care for Prostate Oligoprogressive Cancer

Phase II Interventional Canada

Castrate Resistance Prostate Cancer · OligoProgressive Metastatic Disease

Recruiting NCT05127824☆ Save

Autologous Dendritic Cell Vaccine in Kidney Cancer

Phase II Interventional United States

Carcinoma, Renal Cell

Not yet recruiting NCT07688954☆ Save

Difficult Intubation in HoLEP Surgery

— Observational —

Difficult Intubation · Holmium Laser Enucleation of the Prostate

Not yet recruiting NCT07686055☆ Save

Precision Management of Urinary Tract Symptoms in Older Women

Phase III Interventional United States

Urinary Tract Infection (Diagnosis)

Recruiting NCT06526299☆ Save

Low PSMA SUV Boost (LPS-Boost): Intensified 177Lu-PSMA-617 Treatment for Patients With Metastatic Castrate-Resistant Prostate Cancer With Low PSMA Expressing Disease

Phase II Interventional United States

Metastatic Castration-Resistant Prostate Carcinoma · Stage IVB Prostate Cancer AJCC v8

Recruiting NCT07379814☆ Save

Rectus Abdominis Detrusor Myoplasty for Urinary Retention

— Observational United States

Urinary Retention · Urinary Retention After Procedure · Urinary Retention Postoperative

Recruiting NCT06319820☆ Save

A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer

Phase III Interventional United States, Argentina +18

Non-Muscle Invasive Bladder Neoplasms

Recruiting NCT05348876☆ Save

A Study to Learn More About How Safe Darolutamide is and How Well it Works Under Real World Conditions When Taken in Addition to Standard Androgen Deprivation Therapy (ADT) in Indian Participants With High-risk Non-metastatic Castration-resistant Prostate Cancer (nmCRPC)

Phase IV Interventional India

Non-metastatic Castration-resistant Prostate Cancer

Recruiting NCT05818683☆ Save

A Study of Pasritamig (JNJ-78278343) in Combination With Other Agents for Metastatic Prostate Cancer

Phase I Interventional United States, Australia +1

Metastatic Castration-resistant Prostate Neoplasms · Metastatic Hormone-sensitive Prostate Cancer

Recruiting NCT07227415☆ Save

Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer

Phase I / Phase II Interventional United States, Australia +4

Carcinoma, Renal Cell · Advanced Renal Cell Carcinoma · Renal Cancer

Not yet recruiting NCT07682649☆ Save

Escalating Cycle 1 Dose of Lu-177-PSMA-617 for the Treatment of Metastatic Castration Resistant Prostate Cancer

Phase I Interventional United States

Metastatic Castration-Resistant Prostate Carcinoma · Stage IVB Prostate Cancer AJCC v8

Recruiting NCT04564781☆ Save

Predicting BCG Response

— Observational United States, Australia +1

Bladder Cancer

Not yet recruiting NCT07683013☆ Save

Safety, Tolerability, and Efficacy of CP-PCA07 in Combination With Enzalutamide in Patients With Castration-Resistant Prostate Cancer

Phase I Interventional South Korea

Castration-Resistant Prostate Cancer (CRPC)

Recruiting NCT04829175☆ Save

Ethicon Pelvic Mesh Post Market Clinical Follow-up Registry

— Observational United States, Austria +5

Stress Urinary Incontinence · Pelvic Organ Prolapse

Recruiting NCT07686016☆ Save

Prostate Radiotherapy and Metastasis-Directed Therapy in Synchronous Oligometastatic Prostate Cancer

— Observational Poland

Prostate Cancer · Metastatic Prostate Cancer · Oligometastatic Prostate Cancer

Recruiting NCT05361798☆ Save

A Phase II Study Evaluating T-Cell Clonality After Stereotactic Body Radiation Therapy Alone and in Combination With the Immunocytokine PDS01ADC in Localized High and Intermediate Risk Prostate Cancer Treated With Androgen Deprivation Therapy

Phase II Interventional United States

Cancer Of Prostate

Not yet recruiting NCT07682584☆ Save

Predictors of BCR After RARP for Localized Prostate Cancer: A Retrospective Analysis

— Observational —

Prostate Cancer · Biochemical Recurrence

Recruiting NCT07552168☆ Save

INSPIRE: INnovative SABR for Prostate Cancer All IREland

Phase II Interventional Ireland, United Kingdom

Prostate Adenocarcinoma

Recruiting NCT06976125☆ Save

Application of a Prediction Model for Directing Antibiotic Use in the Treatment of Urinary Tract Infection in an Ambulatory Setting

No phase Interventional United States

Urinary Tract Infections

Recruiting NCT06834152☆ Save

Online Adaptive Stereotactic Body Radiotherapy for Localized Prostate Cancer

— Observational Germany, Switzerland

Localized Prostate Carcinoma · Prostate Cancer (Adenocarcinoma) · Prostate Hyperplasia

Recruiting NCT07319871☆ Save

A Study of Pasritamig (JNJ-78278343) in Combination With JNJ-86974680 for Treatment of Prostate Cancer

Phase I Interventional United States, United Kingdom

Prostatic Neoplasms

Recruiting NCT07223372☆ Save

An Observational Study to Learn More About How Medicines That Block Male Hormones Are Used in People With Prostate Cancer in Australia

— Observational Australia

Metastatic Hormonesensitive Prostate Cancer (mHSPC)

Recruiting NCT06789406☆ Save

PMCF Study of the Axonics SNM System Model 5101 (R20) for the Indication of OAB

No phase Interventional United States, United Kingdom

Urinary Urge Incontinence (UUI) · Urinary Frequency (UF) · Overactive Bladder (OAB)

Recruiting NCT07082920☆ Save

A Study of JNJ-78278343 in Combination With JNJ-95298177 for Treatment of Prostate Cancer

Phase I Interventional United States, United Kingdom

Prostatic Neoplasms

Not yet recruiting NCT07594002☆ Save

Comparing Acupuncture vs. Sham Acupuncture for the Management of Hot Flashes in Prostate Cancer Patients Receiving Hormone Therapy

No phase Interventional United States

Accupuncture · Prostate Cancer · Hormone Therapy

Recruiting NCT07451002☆ Save

A Study to Assess Adherence to Apalutamide in Metastatic Hormone-Sensitive Prostate Cancer Participants in France

— Observational France

Prostatic Neoplasms · Metastatic Hormone-sensitive Prostate Cancer

Recruiting NCT07042256☆ Save

Feasibility of MR-Informed Adaptive Marker-less SBRT in Patients With Bilateral Hip Prostheses Undergoing SBRT for Localized Prostate Cancer

No phase Interventional Switzerland

Localized Prostate Adenocarcinoma

Recruiting NCT04829357☆ Save

Post Market Clinical Follow-up Study on TVT ABBREVO® Continence System

— Observational United States, Italy +1

Stress Urinary Incontinence

Recruiting NCT06514521☆ Save

Post Marketing Study on Pluvicto in Korea

— Observational South Korea

Metastatic Castration-resistant Prostate Cancer

Recruiting NCT07302230☆ Save

Home-Based Physical Activity Program With Digital App Versus Health Education Group for Improving Physical Activity Among Patients With Non-muscle Invasive Bladder Cancer, The EMPOWER Trial

No phase Interventional United States

Localized Non-Muscle Invasive Bladder Urothelial Carcinoma · Stage 0a Bladder Cancer AJCC v8 · Stage 0is Bladder Cancer AJCC v8

Recruiting NCT07647744☆ Save

To Evaluate the Safety and Tolerability of Anti-Human CD70 T-Cell Injection in Subjects With Advanced/Metastatic Renal Cancer

Phase I Interventional China

Renal Cell Carcinoma (RCC)

Recruiting NCT06833073☆ Save

A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)

Phase II Interventional United States, Argentina +17

Urinary Bladder Neoplasms · Non-Muscle Invasive Bladder Neoplasms · Carcinoma in Situ

Recruiting NCT07614594☆ Save

Non-invasive Urinary Genomics-Based Risk Assessment for Early Urothelial Carcinoma Diagnosis

— Observational China

Urothelial Carcinoma (UC) · Upper Tract Urothelial Carcinoma · UTUC

Recruiting NCT07405554☆ Save

Zinc Supplementation With Botulinum Toxin for Overactive Bladder

Phase II Interventional United States

Overactive Bladder (OAB)

Recruiting NCT07226986☆ Save

A Phase Ib/II Open-label Study of AMO959 With Lutetium (177Lu) Vipivotide Tetraxetan (AAA617) in Combination With ARPI in Adult Participants With PSMA-positive mCRPC

Phase I / Phase II Interventional United States, Australia +5

PSMA-positive Metastatic Castration Resistant Prostate Cancer (mCRPC) With Prior Exposure to One Prior ARPI Who Are Candidates for Taxane-based Chemotherapy

Recruiting NCT07140900☆ Save

Study Evaluating the Safety, Tolerability, and Efficacy of Xaluritamig in Combination With Androgen Receptor Pathway Inhibitors in Participants With Metastatic Hormone-sensitive Prostate Cancer

Phase I Interventional United States, Australia +1

Metastatic Hormone-sensitive Prostate Cancer (mHSPC)

Recruiting NCT06085664☆ Save

A Pilot Presurgical Trial of REGN5678 (Anti-PSMA x CD28) in Patients With High-risk, Localized Prostate Cancer Followed by Radical Prostatectomy

Phase I / Phase II Interventional United States

Prostate Cancer · Radical Prostatectomy

Recruiting NCT06813898☆ Save

An Investigational Scan (rhPSMA-7.3 PET/CT) for Detecting Biochemically Recurrent Prostate Cancer, ENLIGHTEN Trial

Early Phase I Interventional United States

Biochemically Recurrent Prostate Carcinoma · Prostate Adenocarcinoma

Not yet recruiting NCT07680920☆ Save

Effects of Combined Training in Prostate Cancer Patients

No phase Interventional —

Prostate Cancer Patients · Androgen Deprivation Therapy

Recruiting NCT07087158☆ Save

A Study of IBR854 Combined With Pazopanib Versus Pazopanib in Advanced Renal Cell Carcinoma

Phase II Interventional China

Renal Cell Carcinoma (RCC)

Recruiting NCT05852041☆ Save

rhPSMA-73 PET-MRI Imaging for the Detection of Prostate Cancer Among Men Who Are Otherwise Candidates for Active Surveillance

Early Phase I Interventional United States

Prostate Adenocarcinoma · Stage I Prostate Cancer AJCC v8 · Stage IIA Prostate Cancer AJCC v8

Recruiting NCT00026884☆ Save

Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease

— Observational United States

Malignant Neoplasms · Hereditary Neoplastic Syndromes · Kidney Cancer

Recruiting NCT06394869☆ Save

Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.

No phase Interventional United States

Hematuria - Cause Not Known

Not yet recruiting NCT07680543☆ Save

ProVIDE Studies Post Exit Analysis

— Observational —

BPH With Symptomatic Lower Urinary Tract Symptoms

Recruiting NCT07483658☆ Save

Non-inferiority Study Comparing Salvage Pelvic Radiotherapy in 25 Fractions (62.5 Gy/25) Versus 20 Fractions (52.5 Gy/20) for Recurrent Prostate Cancer After Surgery.

No phase Interventional Canada

Reccurent/Metastatic Solid Tumor Disease · Prostate Cancer (Post Prostatectomy) · Prostate Cancer

Recruiting NCT04692675☆ Save

Multiparametric Magnetic Resonance Imaging of the Prostate to Assess Disease Progression and Genomics in Patients Undergoing Active Surveillance for Prostate Cancer

No phase Interventional United States

Prostate Cancer

Recruiting NCT02641769☆ Save

Intra-Testicular Transplantation of Autologous Stem Cells for Treatment of Non-Obstructive Azoospermia Male Infertility.

Phase I / Phase II Interventional Jordan

Non-obstructive Azoospermia

Recruiting NCT06100705☆ Save

Sipuleucel-T Combined With Bipolar Androgen Therapy in Men With mCRPC

Phase II Interventional United States

Metastatic Castration-resistant Prostate Cancer

Recruiting NCT06401980☆ Save

Darolutamide in Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Phase II Interventional Switzerland

Metastatic Castration-resistant Prostate Cancer

Recruiting NCT07678489☆ Save

Total en Bloc Urethra Preservation at Robot-assisted Prostatectomy IDEAL Stage 2a

No phase Interventional Germany

Prostate Cancer (Localized), Urinary Incontinence (C61)

Not yet recruiting NCT07387640☆ Save

Synchronized Core-Pelvic Floor Activation in Urinary Incontinence

No phase Interventional Turkey (Türkiye)

Urinary Incontinence,Stress · Stress Urinary Incontinence · Mixed Incontinence Due to Prolapse of Female Genital Organ

Recruiting NCT07611110☆ Save

AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)

Phase III Interventional United States, Australia +15

Metastatic Castration-resistant Prostate Cancer

Not yet recruiting NCT07655557☆ Save

Sexual Health Communication Skills Training Intervention for Patients With Prostate Cancer

No phase Interventional United States

Prostate Cancer

Not yet recruiting NCT07677566☆ Save

177Lu-PSMA-617 Combined With Darolutamide in Neoadjuvant Treatment of High-risk Localized Prostate Cancer: a Prospective, Single-arm, Multi-center Clinical Trial

Phase IV Interventional China

Prostate Cancer · Prostate Cancer Patients

Not yet recruiting NCT07593079☆ Save

Prostate Specific Membrane Antigen (PSMA) Imaging for Detection of Residual and Metastatic Prostate Cancer

Phase II Interventional United States

Prostate Cancer · Recurrent Prostate Cancer · Metastatic Prostate Cancer

Not yet recruiting NCT07675018☆ Save

INterest of the Negative Predictive Value of Integrons in the reduCtion of Large Broad-spectrum anTibiotics Consumption for Urinary Tract infectionS

No phase Interventional France

Drug Resistance, Microbial · Biomarkers · Urinary Tract Infections (UTI's)

Not yet recruiting NCT07643454☆ Save

Comparison of Trans-Stomial Bladder Lithotripsy Using Mini-Percutaneous Equipment Versus Trans-stomial Bladder Lithotripsy Using Flexible Fibroscope, Percutaneous Approach and Open Cystolithotomy in Patients With Continent Catheterizable Urinary Reservoir

— Observational France

Bladder Calculi · Continent Catheterizable Urinary Reservoir · Trans-Stomal Bladder Lithotripsy

Not yet recruiting NCT07677852☆ Save

Sexual and Urinary Dysfunctions in Generalized Myasthenia

— Observational France

Myasthenia Gravis (MG)

Recruiting NCT05951179☆ Save

Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer

Phase II Interventional United States, Argentina +4

Non-muscle Invasive Bladder Cancer

Recruiting NCT07590934☆ Save

Phase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate Cancer

Phase I / Phase II Interventional United States, Australia +5

Metastatic Prostate Cancer

Recruiting NCT07119996☆ Save

Clinical Trial on the Protective Role of Vitamin B3 in Enhancing Immunotherapy for Bladder Cancer Patients

Phase I Interventional China

Bladder (Urothelial, Transitional Cell) Cancer

Not yet recruiting NCT05054790☆ Save

Augmentation Cystoplasty Using an Autologous Neo-Bladder Construct

Phase II Interventional United States

Contracted Bladder

Not yet recruiting NCT07647445☆ Save

Prostate MRI Analysis by Radiologists and Artificial Intelligence - Disease Identification and Guided Management

No phase Interventional —

Prostate CA

Recruiting NCT06432036☆ Save

Yttrium-90 (Y90) Radioembolization for the Treatment of Early Stage Renal Cell Carcinoma, The RENEGADE Trial

Phase I / Phase II Interventional United States

Stage I Renal Cell Cancer · Stage II Renal Cell Cancer

Recruiting NCT06101290☆ Save

Locally Ablative TherapY in Oligo-ProgressiVe GEnitourinary TumoRs (LAYOVER)

No phase Interventional United States

Prostate Cancer · Oligoprogressive · Urothelial Carcinoma

Recruiting NCT06826924☆ Save

7-Days Water-Only Fasting or Ketone Supplementation Trial in Prostate Cancer

No phase Interventional United States

Prostate Cancer · Prostate Cancer Metastatic

Recruiting NCT07313241☆ Save

Phase II Trial of PSA Response-based Androgen Deprivation Therapy and Nodal Coverage for Prostate Cancer Early Salvage Radiotherapy (RANGER)

Phase II Interventional United States

Prostate Cancer

Recruiting NCT06178354☆ Save

Focal Ablation With Focal Cryotherapy or HIFU for the Treatment of Men With Localized Prostate Cancer

No phase Interventional United States

Localized Prostate Carcinoma · Stage I Prostate Cancer AJCC v8 · Stage II Prostate Cancer AJCC v8

Not yet recruiting NCT07574489☆ Save

Whole Versus Partial Gland Boost During Prostate SBRT

Phase II / Phase III Interventional United States

Prostate Cancer · Prostate Adenocarcinoma

Recruiting NCT06568562☆ Save

XL092 in Patients With Metastatic Castration-Resistant Prostate Cancer

Phase II Interventional United States

Metastatic Castration-resistant Prostate Cancer

Not yet recruiting NCT07538843☆ Save

An Observational Study Conducted in China to Evaluate the Efficacy and Safety of Darolutamide in Combination With Androgen Deprivation Therapy (ADT) for Men With Non-metastatic Prostate Cancer That Progressed Following Prior Bicalutamide + ADT Treatment

— Observational China

Non-metastatic Castration-resistant Prostate Cancer

Not yet recruiting NCT07674121☆ Save

PROLONG (PRostateOLaparibONcombinationGcc) Study

— Observational —

Metastatic Castration-resistant Prostate Cancer (mCRPC)

Enrolling by invitation NCT06940648☆ Save

Virtuoso Improving Anatomic Bladder Lesion Excision (VIABLE) Trial

No phase Interventional Hong Kong

Bladder Neoplasm

Recruiting NCT03246802☆ Save

Partial Prostate Salvage High Dose Rate Brachytherapy

No phase Interventional Canada

Recurrent Prostate Cancer

Recruiting NCT07672860☆ Save

Perioperative Ursodeoxycholic Acid for Renal Protection in Adults Undergoing Partial Nephrectomy for Renal Tumors

Phase II Interventional China

Kidney Cancer

Not yet recruiting NCT07652164☆ Save

Water Vapor Ablation for Grade Group 3 Prostate Cancer

No phase Interventional —

Prostate Cancer

Recruiting NCT05806996☆ Save

A Study of Magnesium and Bladder Spasms Following Ambulatory Urologic Procedures

Phase II Interventional United States

Bladder Spasms

Recruiting NCT06202820☆ Save

CV CARE: CardioVascular Care in PC Patients

No phase Interventional United States

Prostate Cancer · Cardiovascular Diseases

Recruiting NCT07174349☆ Save

Uroselective Alpha-1-Antagonist to Reduce the Incidence and Duration of Postoperative Urinary Retention Following Spine Surgery

Phase IV Interventional United States

Urinary Retention Postoperative

Recruiting NCT07673016☆ Save

Specimen Collection for Validation of UroAmp: A Next Generation Sequencing Platform for Detection and Surveillance of Bladder Cancer

— Observational United States, Puerto Rico

Bladder Cancer · Urothelial Carcinoma (UC) · Hematuria

Recruiting NCT07480356☆ Save

Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer

Phase III Interventional United States, Ukraine

Bladder (Urothelial, Transitional Cell) Cancer · Non-Muscle Invasive Bladder Carcinoma · Non-muscle Invasive Bladder Cancer With Carcinoma in Situ

Not yet recruiting NCT07038512☆ Save

Evaluation of Hyivy Floora in Managing Interstitial Cystitis/Bladder Pain Syndrome/High-tone Pelvic Floor Dysfunction

No phase Interventional United States

Interstitial Cystitis/Painful Bladder Syndrome · Interstitial Cystitis, Chronic · High Tone Pelvic Floor Dysfunction

Recruiting NCT07038928☆ Save

TReatment Approaches and bIomarkers preValence in bladdEr Cancer in RuSsian Federation

— Observational Russia

Bladder Cancer

Not yet recruiting NCT07665749☆ Save

Efficacy and Tolerability of Treatment With Alfalitic Plus Serenoa Repens Compared to Alfalitic Plus Antimuscarinic for Moderate-severe Lower Urinary Tract Symptoms

— Observational —

Benign Prostate Hypertrophy(BPH)

Recruiting NCT07591701☆ Save

Efforts to Increase Representation in Prostate Cancer Clinical Trials at Lyndon B. Johnson Hospital

No phase Interventional United States

Prostate Cancer

Recruiting NCT06800313☆ Save

Study of HLD-0915 in Patients With Metastatic Prostate Cancer

Phase I / Phase II Interventional United States, United Kingdom

Metastatic Prostate Cancer

Not yet recruiting NCT07651397☆ Save

Dietary Modulation of Urinary MCP-1 in ADPKD

No phase Interventional —

Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Recruiting NCT07524439☆ Save

Improving the Care of Incontinence-Associated Dermatitis (IAD) Using a Beta-Glucan Cream as a Hydrating and Soothing Agent

No phase Interventional Canada

Fecal Incontinence · Urinary Incontinence · Diaper Rash

Recruiting NCT07232602☆ Save

KEYMAKER-U04 Substudy 04D: A Clinical Study of New Treatments Given With Enfortumab Vedotin and Pembrolizumab in People With Urothelial Cancer (MK-3475-04D/KEYMAKER-U04)

Phase I / Phase II Interventional United States, Chile +6

Bladder Cancer

Recruiting NCT07672119☆ Save

A Study to Learn About Heart-Related Risks in Elderly Men With Advanced Prostate Cancer Treated With Enzalutamide or Darolutamide

— Observational United States

Prostate Cancer

Not yet recruiting NCT07663097☆ Save

Preoperative Anxiety and Surgical Fear in Holmium Laser Enucleation of the Prostate and Transurethral Resection of the Prostate Patients With Benign Prostatic Hyperplasia

— Observational Turkey (Türkiye)

Benign Prostatic Hyperplasia

Recruiting NCT05242744☆ Save

FTT PET/CT in Metastatic Prostate Cancer

— Observational United States

Prostate Cancer Metastatic

Recruiting NCT07321197☆ Save

Radical Nephrectomy With vs Without Template Lymph Node Dissection in High-Risk Renal Cell Carcinoma (T-LND RCC)

No phase Interventional China

Renal Cell Carcinoma (Kidney Cancer)

Recruiting NCT05946213☆ Save

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

Phase III Interventional United States, Canada +2

Prostate Adenocarcinoma · Stage III Prostate Cancer AJCC v8 · Stage IVA Prostate Cancer AJCC v8

Not yet recruiting NCT07663747☆ Save

Enfortumab Vedotin + Pembrolizumab Induction to Spare the Bladder in MIBC

Phase II Interventional Netherlands

Urothelial Bladder Cancer

Not yet recruiting NCT07668063☆ Save

Device for Bladder Control for Men With SCI

Phase I / Phase II Interventional United States

Neurogenic Bladder

Not yet recruiting NCT07667335☆ Save

Enfortumab Vedotin, Pembrolizumab and Quemliclustat for the Treatment of Unresectable Locally Advanced and Metastatic Urothelial Cancer

Phase I / Phase II Interventional United States

Locally Advanced Bladder Urothelial Carcinoma · Locally Advanced Renal Pelvis Urothelial Carcinoma · Locally Advanced Ureter Urothelial Carcinoma